Jane Street Group, LLC Seres Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 20,870 shares of MCRB stock, worth $19,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,870
Previous 707,073 97.05%
Holding current value
$19,200
Previous $509,000 96.27%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.7 - $1.48 $480,342 - $1.02 Million
-686,203 Reduced 97.05%
20,870 $19,000
Q2 2024

Aug 14, 2024
BUY
$0.56 - $1.19 $347,555 - $738,555
620,635 Added 718.01%
707,073 $509,000
Q1 2024

May 15, 2024
SELL
$0.75 - $1.56 $152,886 - $318,004
-203,849 Reduced 70.22%
86,438 $66,000
Q4 2023

Feb 14, 2024
BUY
$0.93 - $2.15 $242,624 - $560,907
260,887 Added 887.37%
290,287 $406,000
Q3 2023

Nov 14, 2023
SELL
$2.33 - $5.07 $117,508 - $255,695
-50,433 Reduced 63.17%
29,400 $69,000
Q2 2023

Aug 14, 2023
BUY
$4.67 - $6.55 $187,981 - $263,657
40,253 Added 101.7%
79,833 $382,000
Q1 2023

May 15, 2023
SELL
$4.95 - $6.09 $25,784 - $31,722
-5,209 Reduced 11.63%
39,580 $224,000
Q4 2022

Feb 14, 2023
BUY
$5.09 - $9.05 $227,976 - $405,340
44,789 New
44,789 $250,000
Q2 2022

Aug 16, 2022
SELL
$2.7 - $7.62 $51,732 - $145,999
-19,160 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$6.3 - $8.84 $863,270 - $1.21 Million
-137,027 Reduced 87.73%
19,160 $137,000
Q4 2021

Feb 15, 2022
BUY
$6.02 - $11.43 $450,494 - $855,341
74,833 Added 91.98%
156,187 $1.3 Million
Q3 2021

Nov 16, 2021
SELL
$5.46 - $22.6 $69,101 - $286,025
-12,656 Reduced 13.46%
81,354 $567,000
Q2 2021

Aug 16, 2021
BUY
$18.46 - $24.36 $350,518 - $462,547
18,988 Added 25.31%
94,010 $2.24 Million
Q1 2021

May 18, 2021
SELL
$17.66 - $28.92 $109,721 - $179,679
-6,213 Reduced 7.65%
75,022 $1.55 Million
Q4 2020

Feb 17, 2021
BUY
$23.25 - $37.73 $1.04 Million - $1.68 Million
44,600 Added 121.74%
81,235 $1.99 Million
Q3 2020

Nov 17, 2020
BUY
$3.74 - $28.74 $83,431 - $641,131
22,308 Added 155.71%
36,635 $1.04 Million
Q2 2020

Aug 17, 2020
BUY
$3.04 - $6.2 $7,919 - $16,151
2,605 Added 22.22%
14,327 $68,000
Q1 2020

May 15, 2020
SELL
$2.64 - $3.82 $120,661 - $174,593
-45,705 Reduced 79.59%
11,722 $42,000
Q4 2019

Feb 14, 2020
SELL
$2.99 - $4.42 $104,413 - $154,350
-34,921 Reduced 37.81%
57,427 $198,000
Q3 2019

Nov 14, 2019
SELL
$2.29 - $4.16 $51,092 - $92,813
-22,311 Reduced 19.46%
92,348 $370,000
Q2 2019

Aug 15, 2019
BUY
$2.28 - $7.35 $261,422 - $842,743
114,659 New
114,659 $369,000

Others Institutions Holding MCRB

# of Institutions
82
Shares Held
40.5M
Call Options Held
304K
Put Options Held
471K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email